Standard Pen Needles Market
Standard Pen Needles Market Forecasts to 2032 – Global Analysis By Drug Type (Insulin, Growth Hormone, GLP-1, and Other Drug Types), Disease Indication, Needle Size, Usability, Mode of Purchase, End User and By Geography
According to Stratistics MRC, the Global Standard Pen Needles Market is accounted for $1.69 billion in 2025 and is expected to reach $3.06 billion by 2032 growing at a CAGR of 8.8% during the forecast period. Standard pen needles are thin, single-use medical needles that connect to insulin pens or similar injection devices. They enable accurate and controlled delivery of medications under the skin. Available in various lengths and thicknesses, these needles are designed to enhance patient comfort and dosing precision. Their disposable nature helps prevent infection and contamination, making them a safe and convenient option for self-administering injectable treatments.
According to the International Diabetes Federation (IDF), over 530 million adults were living with diabetes in 2023, and this number is expected to rise in the coming decades.
Market Dynamics:
Driver:
Increasing patient preference for insulin pens
The growing prevalence of chronic illnesses like diabetes is fueling demand for convenient drug delivery systems. Insulin pens are gaining popularity due to their ease of use, portability, and reduced injection pain compared to traditional syringes. Technological advancements in pen needle design are improving patient comfort and dosage accuracy. As healthcare shifts toward personalized treatment, insulin pens are becoming integral to daily disease management. The rise in elderly populations and improved diagnostic rates are further boosting adoption. Emerging markets are witnessing increased uptake due to expanding access to diabetes care and education.
Restraint:
Shift towards safety pen needles
The transition toward safety pen needles is introducing regulatory and cost-related hurdles for manufacturers. These devices require compliance with stringent safety standards, including mechanisms to prevent needlestick injuries. Incorporating safety features often increases production complexity and cost, impacting profit margins. Smaller players face challenges in meeting global certification requirements like ISO and FDA approvals. The integration of smart technologies such as needle tracking and disposal sensors adds further regulatory scrutiny. These factors can slow down innovation and delay product launches in competitive markets.
Opportunity:
Rising trend of self-administration
The growing trend of self-administered therapies is creating new opportunities for standard pen needles. Patients are increasingly managing chronic conditions at home, driving demand for user-friendly and reliable injection devices. Innovations in needle ergonomics and ultra-thin designs are enhancing comfort and reducing anxiety. Disposable pen needles are gaining traction due to hygiene concerns and infection control protocols. Manufacturers are exploring biodegradable materials and smart packaging to align with sustainability goals. This shift is also supported by telehealth platforms and remote monitoring technologies that empower patient autonomy.
Threat:
Stringent regulations on safety devices
Regulatory frameworks governing safety devices are becoming more complex and demanding. Authorities require extensive clinical validation and documentation before approving new needle technologies. The rise of digital features like dose tracking and connectivity adds layers of compliance challenges. Supply chain disruptions and material shortages can further complicate regulatory timelines. Companies without robust regulatory teams may struggle to navigate evolving standards, especially in cross-border markets. These constraints can hinder innovation and limit the speed of market expansion.
Covid-19 Impact:
Lockdowns and healthcare reprioritization delayed routine diabetes care and elective treatments. However, the crisis accelerated the adoption of home-based care and self-injection practices. Regulatory bodies introduced fast-track approvals for essential medical devices, including pen needles. Digital health platforms and remote consultations supported continuity of care during the pandemic. Post-COVID strategies now emphasize supply chain resilience, automation, and decentralized production to ensure uninterrupted access.
The insulin segment is expected to be the largest during the forecast period
The insulin segment is expected to account for the largest market share during the forecast period, driven by the rising global burden of diabetes and the widespread use of insulin therapy. Technological improvements in insulin delivery systems are enhancing precision and patient adherence. Pen needles designed for insulin pens are becoming more sophisticated, with features like shorter lengths and finer gauges. Healthcare providers are increasingly recommending insulin pens for better glycemic control and reduced injection errors. As insulin therapy becomes more personalized, demand for compatible pen needles continues to surge.
The home healthcare segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the home healthcare segment is predicted to witness the highest growth rate. Rising healthcare costs and patient preference for at-home treatment are driving this shift. Pen needles are essential tools for self-injection, making them central to home-based chronic disease management. Innovations in packaging and needle safety are making these devices more accessible for non-clinical users. Telemedicine and remote monitoring technologies are reinforcing the trend toward decentralized care. As healthcare systems evolve, home healthcare is emerging as a key growth engine for pen needle manufacturers.
Region with largest share:
During the forecast period, the Asia Pacific region is expected to hold the largest market share. Rapid urbanization and increasing diabetes prevalence are fuelling demand across countries like China, India, and Japan. Government initiatives promoting local manufacturing and affordable healthcare are boosting market penetration. The region is witnessing strong adoption of digital health tools and smart injection devices. Strategic collaborations between global brands and regional players are accelerating technology transfer. Investments in healthcare infrastructure and public awareness campaigns are further expanding the user base.
Region with highest CAGR:
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR. The region leads in technological innovation, with advanced needle designs and integrated safety features. Regulatory agencies are streamlining approval processes for next-gen injection devices, encouraging rapid commercialization. High adoption of self-care and remote health management is driving demand for user-friendly pen needles. Healthcare providers are leveraging data analytics and IoT to optimize chronic disease treatment protocols. Robust reimbursement frameworks and strong R&D investments are reinforcing North America’s leadership in this space.
Key players in the market
Some of the key players in Standard Pen Needles Market include Becton, Dickinson and Company, Berpu Medical Technology Co., Ltd., Novo Nordisk A/S, HTL-STREFA, Embecta Corp., GlucoRx Limited, Ypsomed AG, ARKRAY, Inc., B. Braun SE, AdvaCarePharma, Owen Mumford Ltd., Allison Medical, Inc., Terumo Corporation, UltiMed, Inc., and NIPRO Corporation.
Key Developments:
In September2025, BD (Becton, Dickinson and Company) announced a pharmacy automation partnership with Henry Ford Health to develop the health system pharmacy of the future, with an initial focus on a robotic solution that will enable patients to pick up select prescriptions at their convenience 24 hours a day, seven days a week.
In May2025, Novo Nordisk and Septerna, Inc. announced an exclusive global collaboration and license agreement to discover, develop and commercialise oral small molecule medicines for obesity, type 2 diabetes and other cardiometabolic diseases.
Drug Types Covered:
• Insulin
• Growth Hormone
• GLP-1
• Other Drug Types
Disease Indications Covered:
• Diabetes
• Hormone Deficiency
• Obesity
Needle Sizes Covered:
• 4 mm
• 5 mm
• 6 mm
• 8 mm
• 12 mm
Usabilities Covered:
• Disposable Pen Needles
• Reusable Pen Needles
Mode of Purchases Covered:
• Retail
• Online Purchase
• Non-Retail Channels
End Users Covered:
• Hospitals
• Home Healthcare
• Clinics
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Standard Pen Needles Market, By Drug Type
5.1 Introduction
5.2 Insulin
5.3 Growth Hormone
5.4 GLP-1
5.5 Other Drug Types
6 Global Standard Pen Needles Market, By Disease Indication
6.1 Introduction
6.2 Diabetes
6.3 Hormone Deficiency
6.4 Obesity
7 Global Standard Pen Needles Market, By Needle Size
7.1 Introduction
7.2 4 mm
7.3 5 mm
7.4 6 mm
7.5 8 mm
7.6 12 mm
8 Global Standard Pen Needles Market, By Usability
8.1 Introduction
8.2 Disposable Pen Needles
8.3 Reusable Pen Needles
9 Global Standard Pen Needles Market, By Mode of Purchase
9.1 Introduction
9.2 Retail
9.3 Online Purchase
9.4 Non-Retail Channels
10 Global Standard Pen Needles Market, By End User
10.1 Introduction
10.2 Hospitals
10.3 Home Healthcare
10.4 Clinics
10.5 Other End Users
11 Global Standard Pen Needles Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiling
13.1 Becton, Dickinson and Company
13.2 Berpu Medical Technology Co., Ltd.
13.3 Novo Nordisk A/S
13.4 HTL-STREFA
13.5 Embecta Corp.
13.6 GlucoRx Limited
13.7 Ypsomed AG
13.8 ARKRAY, Inc.
13.9 B. Braun SE
13.10 AdvaCare Pharma
13.11 Owen Mumford Ltd.
13.12 Allison Medical, Inc.
13.13 Terumo Corporation
13.14 UltiMed, Inc.
13.15 NIPRO Corporation
List of Tables
1 Global Standard Pen Needles Market Outlook, By Region (2024-2032) ($MN)
2 Global Standard Pen Needles Market Outlook, By Drug Type (2024-2032) ($MN)
3 Global Standard Pen Needles Market Outlook, By Insulin (2024-2032) ($MN)
4 Global Standard Pen Needles Market Outlook, By Growth Hormone (2024-2032) ($MN)
5 Global Standard Pen Needles Market Outlook, By GLP-1 (2024-2032) ($MN)
6 Global Standard Pen Needles Market Outlook, By Other Drug Types (2024-2032) ($MN)
7 Global Standard Pen Needles Market Outlook, By Disease Indication (2024-2032) ($MN)
8 Global Standard Pen Needles Market Outlook, By Diabetes (2024-2032) ($MN)
9 Global Standard Pen Needles Market Outlook, By Hormone Deficiency (2024-2032) ($MN)
10 Global Standard Pen Needles Market Outlook, By Obesity (2024-2032) ($MN)
11 Global Standard Pen Needles Market Outlook, By Needle Size (2024-2032) ($MN)
12 Global Standard Pen Needles Market Outlook, By 4 mm (2024-2032) ($MN)
13 Global Standard Pen Needles Market Outlook, By 5 mm (2024-2032) ($MN)
14 Global Standard Pen Needles Market Outlook, By 6 mm (2024-2032) ($MN)
15 Global Standard Pen Needles Market Outlook, By 8 mm (2024-2032) ($MN)
16 Global Standard Pen Needles Market Outlook, By 12 mm (2024-2032) ($MN)
17 Global Standard Pen Needles Market Outlook, By Usability (2024-2032) ($MN)
18 Global Standard Pen Needles Market Outlook, By Disposable Pen Needles (2024-2032) ($MN)
19 Global Standard Pen Needles Market Outlook, By Reusable Pen Needles (2024-2032) ($MN)
20 Global Standard Pen Needles Market Outlook, By Mode of Purchase (2024-2032) ($MN)
21 Global Standard Pen Needles Market Outlook, By Retail (2024-2032) ($MN)
22 Global Standard Pen Needles Market Outlook, By Online Purchase (2024-2032) ($MN)
23 Global Standard Pen Needles Market Outlook, By Non-Retail Channels (2024-2032) ($MN)
24 Global Standard Pen Needles Market Outlook, By End User (2024-2032) ($MN)
25 Global Standard Pen Needles Market Outlook, By Hospitals (2024-2032) ($MN)
26 Global Standard Pen Needles Market Outlook, By Home Healthcare (2024-2032) ($MN)
27 Global Standard Pen Needles Market Outlook, By Clinics (2024-2032) ($MN)
28 Global Standard Pen Needles Market Outlook, By Other End Users (2024-2032) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
